New treatment option discovered for brain injury patients suffering from aggression
Aggression and anger are among the most common emotional and behavioral symptoms experienced by traumatic brain injury patients -- often resulting in poorer rehabilitation outcomes and negatively affecting patients' relationships with family and friends and their ability to live at home and maintain steady employment. The team of researchers, led by Flora Hammond, MD, chair of the IU School of Medicine Department of Physical Medicine and Rehabilitation and Covalt Professor of Physical Medicine & Rehabilitation, found that in multiple studies of patients with chronic traumatic brain injury and moderate-severe aggression, taking 100 miligrams of the drug Amantadine twice daily appeared to be beneficial in decreasing aggression, from the perspective of the patients. Their findings were published in the newest issue of the Journal of Head Trauma Rehabilitation , for which IU School of Medicine associate professor Dawn M. Neumann, PhD, served as topical issue editor focusing ...